HomeAKRO • NASDAQ
add
Akero Therapeutics Inc
Previous close
$39.96
Day range
$38.74 - $40.50
Year range
$17.86 - $58.40
Market cap
3.10B USD
Avg Volume
1.31M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 80.88M | 34.91% |
Net income | -70.72M | -32.58% |
Net profit margin | — | — |
Earnings per share | -0.90 | 0.00% |
EBITDA | -80.88M | -34.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 686.29M | -24.05% |
Total assets | 1.16B | 26.70% |
Total liabilities | 72.00M | 9.10% |
Total equity | 1.08B | — |
Shares outstanding | 79.72M | — |
Price to book | 2.94 | — |
Return on assets | -20.41% | — |
Return on capital | -21.21% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -70.72M | -32.58% |
Cash from operations | -67.66M | -92.56% |
Cash from investing | -482.18M | -933.52% |
Cash from financing | 395.53M | 7.79% |
Net change in cash | -154.32M | -139.60% |
Free cash flow | -45.85M | -172.02% |
About
Founded
2017
Headquarters
Website
Employees
69
